Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Other Non-Current Liabilities (2016 - 2026)

Neuroone Medical Technologies filings provide 7 years of Other Non-Current Liabilities readings, the most recent being $709507.0 for Q1 2026.

  • On a quarterly basis, Other Non-Current Liabilities fell 47.85% to $709507.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $709507.0, a 47.85% decrease, with the full-year FY2025 number at $1.3 million, down 40.81% from a year prior.
  • Other Non-Current Liabilities hit $709507.0 in Q1 2026 for Neuroone Medical Technologies, down from $806859.0 in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $2.1 million in Q3 2024 to a low of $709507.0 in Q1 2026.
  • Median Other Non-Current Liabilities over the past 3 years was $1.3 million (2025), compared with a mean of $1.3 million.
  • The widest YoY moves for Other Non-Current Liabilities: up 40.81% in 2025, down 53.92% in 2025.
  • Neuroone Medical Technologies' Other Non-Current Liabilities stood at $1.8 million in 2024, then plummeted by 53.92% to $806859.0 in 2025, then fell by 12.07% to $709507.0 in 2026.
  • The last three reported values for Other Non-Current Liabilities were $709507.0 (Q1 2026), $806859.0 (Q4 2025), and $1.3 million (Q3 2025) per Business Quant data.